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Diet-induced  obesity  (DIO)  causes  ghrelin  resistance  in  hypothalamic  Agouti-related  peptide  (AgRP)  neu-
rons. However,  ghrelin  promotes  feeding  through  actions  at both  the  hypothalamus  and  mesolimbic
dopamine  reward  pathways.  Therefore,  we hypothesized  that  DIO would  also  establish  ghrelin  resis-
tance  in  the  ventral  tegmental  area  (VTA),  a major  site  of  dopaminergic  cell  bodies  important  in  reward
processing.  We  observed  reduced  sucrose  and  saccharin  consumption  in Ghrelin  KO vs  Ghrelin  WT  mice.
Moreover,  DIO  reduced  saccharin  consumption  relative  to chow-fed  controls.  These  data  suggest  that  the
deletion of  ghrelin  and  high  fat  diet  both  cause  anhedonia.  To  assess  if these  are  causally  related,  we  tested
whether  DIO  caused  ghrelin  resistance  in  a classic  model  of drug  reward,  conditioned  place  preference
(CPP).  Chow  or  high  fat diet  (HFD)  mice  were  conditioned  with  ghrelin  (1 mg/kg  in 10  ml/kg  ip) in the
presence  or  absence  of food  in the conditioning  chamber.  We  observed  a CPP to ghrelin  in  chow-fed  mice
but  not  in  HFD-fed  mice.  HFD-fed  mice  still  showed  a CPP  for  cocaine  (20  mg/kg),  indicating  that  they
maintained  the ability  to develop  conditioned  behaviour.  The  absence  of food  availability  during  ghrelin
conditioning  sessions  induced  a conditioned  place  aversion,  an effect  that was  still present in both  chow
and  HFD  mice.  Bilateral  intra-VTA  ghrelin  injection  (0.33 g/l in 0.5  l) robustly  increased  feeding  in
both  chow-fed  and high  fat  diet  (HFD)-fed  mice;  however,  this  was  correlated  with  body  weight  only  in
the  chow-fed  mice.  Our results  suggest  that DIO  causes  ghrelin  resistance  albeit  not directly  in  the  VTA.
We suggest  there  is  impaired  ghrelin  sensitivity  in upstream  pathways  regulating  reward  pathways,
highlighting  a functional  role  for  ghrelin  linking  appropriate  metabolic  sensing  with  reward  processing.
© 2015  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND. Introduction
Ghrelin is a 28 amino acid peptide secreted from the stomach
o signal negative energy balance. It is the endogenous ligand of
he growth hormone secretagogue receptor (GHSR1a) (Andrews,
011), but must be esteriﬁed with an acyl group for full efﬁcacy at
his receptor. It is the only known circulating factor that increases
ood intake and has a well-described role in promoting feeding
hrough hypothalamic circuits (Andrews, 2011). The GHSR1a is
ighly expressed in the hypothalamus with highest levels in the
rcuate nucleus (Zigman et al., 2006), where it is colocalised with
90% of neuropeptide Y (NPY) neurons (Willesen et al., 1999).
hrelin’s ability to increase food intake requires Agouti-related
∗ Corresponding author. Fax: +61 399029500.
E-mail address: zane.andrews@monash.edu (Z.B. Andrews).
ttp://dx.doi.org/10.1016/j.psyneuen.2015.08.004
306-4530/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article 
/).license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
peptide (AgRP) and NPY neurons, as ablation of AgRP neurons pre-
vents ghrelin-induced food intake (Luquet et al., 2007).
The GHSR1a is also found on midbrain dopamine neurons in
the substantia nigra (Andrews et al., 2009) and ventral tegmen-
tal area (VTA) (Abizaid et al., 2006). The cell bodies of dopamine
neurons located in the VTA form a key component of the brain
reward circuitry and ghrelin injected into the VTA or nucleus
accumbens elicits food intake (Abizaid et al., 2006; Naleid et al.,
2005). Re-expression of GHSR1a only on tyrosine hydroxylase
(TH) neurons, a population that includes dopamine neurons, par-
tially restores ghrelin-induced food intake (Chuang et al., 2011),
suggesting that the ability of ghrelin to fully induce food intake
requires both GHSR1a signalling in arcuate (ARC) AgRP neurons
and TH neurons, the latter presumably via reward processing.
Behavioural and physiological evidence shows that ghrelin plays
a key role in reward processing. Exogenous ghrelin administration
increases appetitive drive or motivated responding in a number of
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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ehavioural paradigms including progressive ratio response tasks
Skibicka et al., 2011). Conversely, lack of ghrelin signalling dis-
upts behavioural responses to other drugs such as cocaine, nicotine
nd alcohol (Abizaid et al., 2011; Jerlhag et al., 2010, 2009). These
ndings indicate that ghrelin is critical for processing of reward
nformation.
Conditioned place preference/aversion (CPP/CPA) is a com-
only used behavioural task to assess the rewarding or aversive
ature of particular stimuli. It has been used extensively to test the
otivational properties of drugs of abuse in rodents (Tzschentke,
007). There is considerable literature around ghrelin’s ability to
otentiate the effectiveness of the unconditioned stimulus in the
PP test. Ghrelin given in conjunction with cocaine increases the
trength of the preference for the paired compartment (Davis et al.,
007), whereas GHSR1a antagonism attenuates CPP to nicotine
Jerlhag and Engel, 2011), cocaine, and amphetamine (Jerlhag et al.,
010). Ghrelin knockout mice also show deﬁcits in forming a CPP
n response to ethanol (Bahi et al., 2013). Ghrelin given during the
onditioning days of a CPP protocol, or on the test day only, pro-
otes a conditioned place preference in response to a high fat diet
ellet (Perello et al., 2010). Others have shown that ghrelin alone, at
elatively low doses, is able to condition a place preference (Jerlhag,
008).
Our group previously demonstrated that the hypothalamus
ecomes resistant to ghrelin signalling after periods of high fat diet
HFD) feeding, which is accompanied by a pronounced functional
ollapse in the NPY/AgRP neurons of the ARC (Briggs et al., 2010).
hese deﬁcits occur after several weeks of HFD feeding (Briggs
t al., 2014), and persist while body weight remains high, but can
e reversed with diet-induced weight loss (Briggs et al., 2013).
thers have recently demonstrated ghrelin resistance in the vagal
fferents and nodose ganglion, suggesting that this phenomenon
s not limited to the hypothalamus (Naznin et al., 2015). The inter-
ction between HFD feeding and reward processing is as yet not
ell understood, however ghrelin resistance appears to extend to
ehavioural measures beyond feeding. In chow fed rats, ghrelin
ncreases responding on a progressive ratio task, however it is inef-
ective in altering responding in obese rats (Finger et al., 2012). It
s currently unclear exactly how HFD feeding effects other ghrelin-
esponsive cell populations, such as those in the VTA, and whether
his has functional effects for mouse behaviour and reward pro-
essing.
In this study we aimed to examine how HFD affects the role of
hrelin in reward processing. We  hypothesised that ghrelin resis-
ance would be present in the VTA, and that this would produce
 number of deﬁcits in behavioural tasks associated with reward
rocessing and consolidation.
. Methods
.1. Mice and housing
Male C57Bl/6J mice were obtained at 9–10 weeks old from
onash Animal Services, Victoria, Australia, and were group
oused (4 per cage) under controlled conditions (21 ◦C and 12:12 h
ight/dark cycle) and maintained on chow diet or HFD with free
ccess to food and water. The chow diet (rat and mouse pellets,
pecialty feeds, Western Australia) contained 20% protein, 4.8%
otal fat, 4.8% crude ﬁbre, and 14 kJ/g of digestible energy. The
FD (SF04-001, specialty feeds, Western Australia) contained by
eight: 22.6% protein, 23.5% fat, 20% sucrose, 20% starch, 5.4% crude
bre with an energy content of 19 kJ/g. Experiments were con-
ucted in accordance with the Monash University Animal Ethics
ommittee guidelines. For experiments undertaken at time points
n HFD, mice were trained during the last two  weeks of HFD feed-crinology 62 (2015) 114–120 115
ing. Ghrelin knock out mice (ghrelin KO) and wildtype littermates
(ghrelin WT)  were obtained from Regeneron Pharmaceuticals and
back crossed to C57Bl/6J. Mice were bred at Monash Animal Ser-
vices and housed as above.
2.2. Drugs
Ghrelin (PolyPeptide group, Strasbourg, France) and cocaine
(Glaxo Australia, Pty Ltd.) were given by intraperitoneal injection,
in a volume of 10 ml/kg, dissolved in isotonic saline. Isotonic saline
acted as the vehicle for all injections. A dose of 1 mg/kg was  cho-
sen for intraperitoneal ghrelin administration following a dose
response (Fig 1A), as this dose gave a large and reliable increase
in food intake. Intra VTA ghrelin was  given bilaterally at 0.5 g in
a volume of 0.5 l. Cocaine was given at a dose of 20 mg/kg, as
previous experience indicated this dose reliably conditions a place
preference in C57black/6 mice (Bird et al., 2014; McPherson et al.,
2010). All drugs were dissolved fresh on day of administration.
Sucrose (CSR, Australia) and Saccharin (Sigma, Australia) were
dissolved in tap water at concentrations of 10% and 0.1% (w/v),
respectively. These concentrations were used as they reliably
increase ﬂuid consumption.
2.3. VTA cannulations
Mice were anaesthetised using isoﬂurane (5% induction, 2%
maintenance in oxygen) and 26 G bilateral cannulae (Plastics One
Inc., Roanoke, VA, USA) aimed at the VTA (coordinates relative to
bregma in mm;  anterior posterior = −3.2, medial lateral = 0.6, dor-
sal ventral = −4.6) were implanted. Cannulae were ﬁxed to the scull
using light-curing dental cement (G-bond and G-aenial Universal
Flo, GC, Henry Schein Halas). Following surgery, mice were given
metacam as a post-operative analgesic and allowed at least 7 days
recovery before injections commenced. Cannula placement was
histologically veriﬁed post mortem.
We performed a dose response and identiﬁed 0.33 g/l  as the
lowest effective dose of ghrelin in the VTA to elicit food intake, this
was subsequently used for all feeding studies in a 0.5 l injection
volume.
2.4. Sucrose and saccharin two bottle choice
Mice were trained for 4 days in the two  bottle choice test,
and then consumption was  measured on day 5. Mice were water
deprived overnight before ﬁrst exposure. Mice were removed from
their group-housed home cage and placed individually in fresh
cages without bedding, and two bottles in the cage lid, one with
water and one with sweetener (either 10% w/v sucrose or 0.1% w/v
saccharin) and allowed 90 min to consume from either bottle, then
returned to group housing. This procedure was repeated with water
restriction on day 2, and without water restriction on days 3 and 4,
with bottles alternating sides on each day. On test day, bottles were
randomly assigned a side and consumption in the 90 min  window
was measured for both bottles.
2.5. CPP methods
Conditioned place preference testing was  performed in custom-
made boxes. Boxes were constructed of plexiglass and contained
two side zones (28 cm × 21 cm)  and a middle zone (21 cm × 9 cm),
with the middle zone being divided from the end zones by opaque
white plexiglass walls. Each end zone was differentiated by wall
pattern and ﬂoor texture. The middle compartment contained but-
ton lights ﬁxed to the wall to increase illumination and discourage
mice from spending time there during testing. Light levels were
19 lumens in the centre compartment and 5.25 lumens in the
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Fig. 1. (A) 10% (w/v) sucrose solution consumption is signiﬁcantly reduced in ghrelin KO mice relative to ghrelin WT mice (B) after 3 weeks of high fat diet consumption this
difference is abolished. (C) 0.1% (w/v) saccharin solution consumption is signiﬁcantly reduced in ghrelin KO mice relative to ghrelin WT mice. (D) 0.1% saccharin preference
is  signiﬁcantly reduced in C57black/6 mice on a HFD for 3 weeks. ***p < 0.001 compared to WT  + sucrose or saccharin; ***p < 0.01 compared to chow + saccharin; two  way
ANOVA  followed by Bonferroni comparison.
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hnd zones. Familiarisation trials were ﬁlmed and scored for initial
reference. Mice spending between 45% and 55% spent on either
ide were considered to have no initial preference (unbiased). Any
ouse spending <45% was allocated a conditioning side in a biased
anner, pairing the test treatment with the non-preferred side.
ypically fewer than 30% of mice ﬁtted into this category. For
hrelin conditioning, ghrelin or saline were administered IP on
lternating days for 11 days (6 ghrelin days, 5 saline days). Condi-
ioning sessions lasted 20 min. In all conditioning trials mice were
njected with either ghrelin or saline and placed back in their home
age for no more than 5 min, then placed in the conditioning boxes.
ocaine conditioning occurred for 7 days (4 cocaine days, 3 saline
ays). Mice were injected with cocaine and placed in the condi-
ioning chamber for 20 min. The preference score equals the time
pent in the speciﬁed conditioning compartment divided by the
otal time spent in both compartments, excluding the middle neu-
ral zone, multiplied by 100 (Brown et al., 2009). All trials were
lmed and later scored, by an experimenter blinded to the treat-
ent groups, using Ethovision software (Ethovision XT; Noldus
nformation Technology; Wageningen, The Netherlands) to elec-
ronically track mice and generate scores. The compartments were
horoughly washed with mild detergent in warm water between
rials.
.6. StatisticsAll data are reported as the mean ± sem. Student’s unpaired t-
ests were used to assess differences in body weight. All other data
ets were examined using a one-way or two-way ANOVA with post
oc analysis as indicated in the text.3. Results
We  ﬁrst investigated sucrose solution consumption in Ghrelin
KO mice. When eating a chow diet, ghrelin KO mice had signiﬁ-
cantly reduced consumption of a 10% sucrose solution compared
to WT  littermates (Fig 1A; F(1,36) = 23.09, p < 0.001). Sucrose solu-
tion consumption was measured again in the same mice after three
weeks of HFD feeding, at which time there was no longer a signiﬁ-
cant difference in consumption between WT  and KO mice (Fig 1B;
F(1,33) = 0.263, p > 0.05). Considering caloric content contributes
to the rewarding properties of sucrose, we next sought to exam-
ine whether removal of caloric content lead to similar results by
using saccharin. Chow fed ghrelin KO mice also had signiﬁcantly
reduced saccharin solution consumption compared to WT mice
(Fig 1C; F(1,40) = 4.616, p < 0.05). Similarly, HFD itself caused anhe-
donia, as shown in Fig 1D, where a 3-week HFD exposure caused
reduced saccharin solution consumption relative to chow-fed wild-
type mice (F(1,34) = 15.87, p < 0.001). These results suggest that
ghrelin is involved in the normal processing of hedonic responses
to saccharin or sucrose and that the loss of ghrelin signalling due
to ghrelin resistance in DIO mice may  contribute to the anhedonia
noted in HFD vs chow fed mice.
To investigate if the 3 weeks of HFD causes ghrelin resistance
in reward pathways, we  designed experiments to test the function
of ghrelin on well-deﬁned condition place preference behaviour
in mice fed chow or HFD. We  selected a dose of 1 mg/kg based
on a dose response study (Fig 2A F(3) = 8.622, p < 0.001), as this
dose reliably and potently induced eating. Three weeks of HFD
feeding produced signiﬁcantly heavier mice in the HFD group
(Fig 2B, t(46) = 6.763, p < 0.001), and these mice also had signiﬁ-
cantly worse glucose tolerance (Fig 2C, F(2,17) = 27.09, p < 0.001).
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Fig. 2. (A) Ghrelin dose response in chow fed C57black/6 mice, p < 0.05, ***p < 0.001, one way ANOVA. (B) Three weeks of HFD feeding results in signiﬁcantly increased
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onditioned compartment before and after conditioning, (D) with food present duri
ay.  *p < 0.05 ***p < 0.01 ***p < 0.001, 2 way RM ANOVA, Sidak’s multiple compariso
hen mice were conditioned with food present in the conditioning
oxes, ghrelin (1 mg/kg ip) produced a signiﬁcant shift in prefer-
nce for the conditioned side relative to pre-conditioning (Fig 2D,
(2,64) = 12.3, p < 0.01, Sidak’s multiple comparison test). This effect
as absent in HFD-fed mice conditioned with ghrelin, suggesting
hat HFD prevents the ability of ghrelin to condition a place pref-
rence (Fig 2D). We  included a group of HFD fed mice conditioned
ith cocaine to ascertain whether these mice could form a CPP
iven an appropriate unconditioned stimulus. This group showed
 strong shift in preference for the cocaine-paired side, relative to
re-conditioning (Fig 2D, Sidak’s multiple comparison test), indi-
ating that HFD mice are capable of forming a CPP. We  repeated
he experiment without food in the conditioning boxes during
onditioning trials, and observed the opposite effect of ghrelin on
reference. Chow fed mice treated with ghrelin in the absence of
ood showed a signiﬁcant aversion for the conditioned side relative
o pre-conditioning, and interestingly this effect was  preserved in
ice on a HFD (Fig 2E, F(1,36) = 14.44 p < 0.01).
Our data indicated DIO induces ghrelin resistance in pathways
egulating a CPP but not a CPA. To test whether DIO causes direct
hrelin resistance in the VTA, we measured food intake after intra-
TA ghrelin injection as a proxy for ghrelin action on VTA dopamine
eurons. Administration of ghrelin directly into the VTA increased
eeding in chow fed and HFD mice over a two hour period (Fig 3A,
(2,68) = 18.20, p < 0.001,), suggesting a lack of ghrelin resistance to
ntra-VTA ghrelin in HFD mice. To investigate this further we  used
inear regression to correlate each animal’s ghrelin-induced food
ntake with its body weight on a chow or HFD. There was no cor-
elation between intra-VTA aCSF food intake in chow or HFD mice
Fig. 3B, r2 = 0.04 and 0.05, respectively). Intriguingly, we observed a
orrelation between body weight and food intake in chow fed mice001, main effect of diet 2 way RM ANOVA. Conditioned place preference scores for
ditioning and on test day, and (E) with food absent during conditioning and on test
injected with ghrelin into the VTA (Fig 3C, r2 = 0.38). This relation-
ship was  absent in mice eating a HFD diet (Fig. 3C, r2 = 0.03). These
results suggest that although HFD did not impair intra-VTA ghrelin-
induced food intake relative to chow animals, the ability of HFD
mice to sense and integrate metabolic information and coordinate
an appropriate feeding response was compromised.
4. Discussion
We previously described that HFD exposure for 12 weeks
induces ghrelin resistance in hypothalamic NPY/AgRP neurons
(Briggs et al., 2010). Subsequent time course studies show that
this ghrelin resistance occurs after just 3 weeks exposure to HFD
(Briggs et al., 2014) and that ghrelin resistance was reversible after
diet-restricted weight loss (Briggs et al., 2013). In this study, we
determined if HFD causes ghrelin resistance in the VTA, a key node
for reward processing.
We report 4 key ﬁndings; (1) HFD does not affect the ability of
intra-VTA ghrelin to increase food intake, although it does interfere
with appropriate portion control; (2) HFD prevents a ghrelin-
induced CPP, as observed in chow mice; (3) the ability of ghrelin to
condition a place preference depends on the presence of food dur-
ing the conditioning period and (4) in the absence of food ghrelin
is a physiological signal that encodes negative valence and leads
to a conditioned place aversion. Collectively, these data support
the idea that HFD causes ghrelin resistance in extra-hypothalamic
pathways regulating reward behaviour.Intra-VTA delivery of ghrelin increases feeding and operant
responding for sucrose in chow fed animals, showing that ghrelin
targets VTA dopamine neurons to increase food intake (Abizaid
et al., 2006; Naleid et al., 2005). This is supported by genetic studies
118 S.H. Lockie et al. / Psychoneuroendocrinology 62 (2015) 114–120
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(ig. 3. (A) Intra-VTA ghrelin injection increases food intake in both chow and HFD-
ody  weight correlates with the intra-VTA ghrelin-induced feeding response in cho
hereby restoring GHSRs only in TH-expressing neurons partially
estores feeding behaviour (Chuang et al., 2011). Interestingly, in
he present study intra-VTA ghrelin robustly increased food intake
n mice on both a chow and HFD suggesting HFD per se does
ot cause ghrelin resistance directly in the VTA. However, intra-
TA injection represents a non-physiological source of exogenous
hrelin into the VTA and studies show that peripheral ghrelin access
nto the brain is largely limited to the hypothalamus (Cabral et al.,
013, 2014). When we performed linear regression analysis we
bserved a clear correlation between intra-VTA ghrelin-induced
eeding and body weight in chow, but not HFD mice. These
esults point towards a relationship between functional sensing of
etabolic state (body weight) and intra-VTA ghrelin responsive-
ess. Since intra-VTA ghrelin increases food intake equally in both
how and HFD fed mice, we posit that the ability to sense metabolic
tate (body weight) is regulated in upstream neural circuits that
egulate VTA dopaminergic pathways.
One potential upstream neural target may  be hypothalamic
gRP neurons. Firstly, AgRP neurons inﬂuence dopamine-related
ehaviours unrelated to feeding, such as cocaine responsiveness
Dietrich et al., 2012) and secondly, AgRP neurons increase moti-
ation to obtain food and food seeking behaviour (Krashes et al.,
011). Recent evidence suggests that direct activation of AgRP neu-
ons can encode a negative valence signal and acts as a negative
einforcer, while silencing these neurons in the face of hunger is
ewarding (Betley et al., 2015). As AgRP neurons are the canonical
arget of ghrelin, our ﬁnding support the idea that ghrelin-induced
ctivation of AgRP neurons in the absence of food may  act in a sim-
lar way to condition the aversion seen in the current experiments.
iven HFD causes ghrelin resistance in AgRP neurons (Briggs et al.,
010), we hypothesise that this impairs the ability of AgRP neurons
o communicate metabolic state with dopamine reward systems in
he VTA. This suggestion requires further experimental evidence.
CPP is a behavioural task based on the association of an internal
eward state established by an exogenous treatment (i.e. ghrelin in
ur experiments) and a context. The ability of an animal to form a
onditioned place preference to drugs of reward such as cocaine,
mphetamine, morphine, alcohol and heroin requires a functional
esolimbic dopamine system (Chen et al., 2006; Hoffman and
eninger, 1989; Spyraki et al., 1987; Walker and Ettenberg, 2007).
ncreased ghrelin levels potentiate the motivational effects of a
umber of substances, including cocaine, alcohol and amphetamine
Dickson et al., 2011). Our data support previous studies showing
hat ghrelin induces a CPP by regulating the mesolimbic dopamine
ystem (Jerlhag, 2008). Peripheral or central ghrelin in mice pro-
otes dopamine availability in the nucleus accumbens, while
ntagonism of the GHSR reduces drug-induced dopamine release
Abizaid et al., 2006; Jerlhag et al., 2007; Jerlhag and Engel, 2011).ice. (B) No correlations were observed in mice injected with aCSF into the VTA. (C)
 not HFD mice, linear regression analysis.
Therefore the inability of ghrelin to induce a CPP in HFD mice
supports the idea the ghrelin resistance occurs in pathways con-
trolling reward behaviours, including non-dopaminergic inputs. It
is important to note that this is not just a phenomenon associ-
ated with speciﬁc CPP behaviour as ghrelin resistance has also been
observed in operant based motivational tasks in diet-induced obese
rats (Finger et al., 2012).
The rewarding effects of cocaine and amphetamine are dimin-
ished following high fat diet feeding (Davis et al., 2008; Wellman
et al., 2007). It remained possible that HFD would cause an atten-
uated conditioned response; therefore we used cocaine to conﬁrm
that HFD mice were still capable of forming a conditioned place
preference. Our results show that mice retain the ability to form a
conditioned response to cocaine with HFD feeding, strongly indi-
cating that our conditioning and testing protocol is robust and valid.
One of the most striking observations from our study is that
the ability of ghrelin to induce a CPP depends on food availabil-
ity during the conditioning sessions, as the absence of food led
to a conditioned place aversion. A similar phenomenon has been
observed with locomotor behaviour, as ghrelin initiates locomotor
behaviour in the absence of food but not in the presence of food
(Jerlhag et al., 2006; Tang-Christensen et al., 2004). The increase in
locomotor behaviour is interpreted as food-seeking behaviour and
acute activation of AgRP neurons, the key neural target for ghrelin-
induced food intake, increases locomotor behaviour in the absence
but not presence of food. AgRP neurons convey the sense of hunger
and recent evidence highlights that AgRP activation in the absence
of food intake can lead to repetitive complex behaviours that are
reversed by food consumption (Dietrich et al., 2015). Thus, the pres-
ence or absence of food after ghrelin injection elicits distinctive
opposing behavioural patterns. As noted above, remote activation
of AgRP neurons encodes a negative valence signal that produces
a CPA and silencing AgRP neurons in fasted mice produces a CPP
(Betley et al., 2015). Our results produced with ghrelin administra-
tion show the same observations and suggest that plasma ghrelin
may  be the physiological signal that links metabolic state (hunger)
with the negative valence encoded by artiﬁcial activation of AgRP
neurons (Betley et al., 2015).
Intriguingly there also appears to be a dual role of ghrelin in
anxiety-like behaviour with ghrelin suppressing anxiety in stressful
situations but not during non-stressful conditions (Spencer et al.,
2012). Moreover, acute ghrelin appears to drive anxiety whereas
chronic ghrelin reduces anxiety, (for review (Spencer et al., 2015)).
Thus, we believe that conditioning animals to ghrelin in the absence
of food may  acutely drive an aversive internal state, perhaps due
to anxiety from an excessive hunger signal, leading to the forma-
tion of a CPA. The most remarkable aspect of the ghrelin-induced
CPA in the absence of food is that it is not affected by diet-induced
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besity, as both chow and HFD mice show a CPA under these con-
itioning parameters. This suggests the possibility that different
eural circuits controlling ghrelin-induced CPP or CPA exist. The
escription that different subpopulations of hunger-sensitive AgRP
eurons drive feeding or non-feeding related behaviours (Betley
t al., 2013) together with evidence that AgRP neurons drive repet-
tive stereotypic behaviour independent of hunger state (Dietrich
t al., 2015) support this idea.
Our results suggest that ghrelin KO are anhedonic based on
reference for saccharin or sucrose, indicating that calorie content
oes not affect the behavioural output. Overdiun et al. showed that
hrelin strongly promotes motivated behaviour but does not seem
o affect the “pleasantness” of taste stimuli (Overduin et al., 2012).
owever, a number of previous studies show ghrelin increases
ocaine effectiveness (Davis et al., 2007; Wellman et al., 2008), and
hat mice lacking ghrelin signalling show deﬁcits in their responses
o nicotine or alcohol (Jerlhag et al., 2009, 2011). Collectively, our
accharin and sucrose data together with the results above suggest
hrelin acts an ampliﬁer of other pleasurable stimuli rather than
eing intrinsically rewarding itself. HFD-fed mice had a similar dis-
nterest in the sucrose and saccharin solutions, which points toward
hrelin resistance being a driver of this reduced hedonic tone. It is
ikely, however, that the reduction in preference for sweet taste
ollowing HFD exposure is multifactorial.
In summary, our results suggest ghrelin resistance occurs in
athways regulating CPP behaviour as an index of reward process-
ng. However these data do not support direct ghrelin resistance
n dopamine neurons in the VTA since the feeding response to
ntra-VTA ghrelin was not signiﬁcantly different between chow
nd HFD fed mice. Our results also suggest that diet-induced obe-
ity impairs metabolic sensing in ghrelin-resistant hypothalamic
tructures inﬂuencing mesolimbic dopamine pathways. Presum-
bly ghrelin is part of the metabolic signal that communicates
omeostatic information to mesolimbic dopaminergic pathways
Lockie and Andrews, 2013). Our results, together with previ-
usly published reports of ghrelin resistance in NPY/AgRP neurons
Briggs et al., 2010, 2014) support the concept that DIO broadly ini-
iates ghrelin resistance in the brain. The physiological relevance
f ghrelin resistance may  represent a mechanism that protects a
igher body weight set point established by HFD. Indeed, ghrelin
esistance does not prevent weight gain on a HFD (Perez-Tilve
t al., 2011), but rather protects against diet-induced weight loss
hen ghrelin sensitivity is reinstated upon reducing calorie intake
Briggs et al., 2013). The presence of ghrelin resistance in both the
omeostatic and reward-processing systems suggests diet-induced
eight loss will be rapidly countered by both systems, defending
gainst excessive weight loss. Understanding these mechanisms
ay  help design treatment strategies that maximise diet-induced
eight loss and prevent rebound weight gain often seen in chronic
ieters.
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